Sanofi

Intro and history: Sanofi is a multinational pharmaceutical company headquartered in Paris, France. It was founded in 2004 as a result of the merger between Sanofi-Synthélabo and Aventis. Today, Sanofi is one of the world's largest pharmaceutical companies by prescription sales, with a strong presence in vaccines, over-the-counter healthcare, and central nervous system, diabetes, and cardiovascular disease treatments. Industry: Pharmaceutical Product, Services and Operations: Sanofi operates in the prescription medicines, vaccines, and consumer healthcare markets. It has a diverse portfolio of drugs with a focus on diabetes, rare diseases, multiple sclerosis, oncology, and immunology. The company also has a significant presence in emerging markets. Funding Details: Being a publicly traded company, Sanofi's funding comes from its operations and investors who buy its shares. As of 2020, its market capitalization was approximately $126 billion. Acquisitions: Sanofi has made several notable acquisitions over the years, including Genzyme in 2011, Bioverativ in 2018, and Synthorx in 2020. Awards and Achievements: Sanofi has received numerous awards and recognitions for its contributions to the pharmaceutical industry. It was ranked 2nd in Access to Medicine Index in 2018, and its products have won several Prix Galien awards, which recognize outstanding innovation in drugs and medical technology.